At the 12 mg dose, participants lost a mean of 24.2% of body weight versus 2.1% with placebo
GLP-1 receptor agonists were originally approved for the treatment of type 2 diabetes, though given the prevalence of GLP-1 receptors in various peripheral tissues, more recent studies have started to look at additional etiologies for which GLP-1 agonists could be a feasible therapeutic option, including MASLD
Metformin Metformin is one of the few medications considered generally safe during breastfeeding that also supports weight management
Tensiometry investigation took place by measuring the tensile breaking force and relative elongation of the damaged skin immediately after euthanasia and at days 7 and 14
Dermal Fillers : Injectable solutions such as hyaluronic acid (Juvederm, Restylane) or collagen-stimulating agents ( Sculptra ) replace lost volume, filling folds and rejuvenating hollow regions
These findings indicate that GLP-1R activation specifically inhibits GSDMD-mediated microglial pyroptosis, a finding consistently replicated in subsequent in vitro experiments (Song et al., 2022)